Cargando…
Ⅰ、Ⅱ相药物代谢酶遗传多态性与晚期非小细胞肺癌化疗疗效的关系
BACKGROUND AND OBJECTIVE: Currently available studies on the polymorphisms of drug-metabolizing enzymes and their chemotherapeutic effects in non-small cell lung cancer are not consistent. In the present study, the relationship of the gene polymorphisms of cytochrome P450 1A1 (CYP1A1), cytochrome P4...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999999/ https://www.ncbi.nlm.nih.gov/pubmed/22104220 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.05 |
Ejemplares similares
-
ERCC1基因多态性与晚期非小细胞肺癌患者铂类化疗疗效的关系
Publicado: (2010) -
XRCC1和XRCC3单核苷酸多态性与晚期非小细胞肺癌铂类药物化疗疗效的相关性
Publicado: (2011) -
EGFR基因状态与晚期非小细胞肺癌患者一线化疗疗效的关系
Publicado: (2015) -
BIM基因多态性与复治晚期非小细胞肺癌EGFR-TKI治疗疗效的关系
Publicado: (2013) -
ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系
Publicado: (2017)